Ticker Launch

SPAC · Merger completed

Amplitude Healthcare Acquisition Corp

Business combination with Jasper Therapeutics, Inc.

Amplitude Healthcare Acquisition Corp is a blank-check company (SPAC) that raised $100M in its initial public offering on Nov 21, 2019, listing on NYSE. It completed its business combination with Jasper Therapeutics, Inc. on Sep 24, 2021; the combined company is Jasper Therapeutics, Inc. (JSPR). American Express Company led the IPO, with Morgan Stanley and Bone. Ellenoff Grossman & Schole advised the SPAC and Mayer Brown advised the underwriters on the IPO.

Jasper Therapeutics is a biotechnology company developing curative therapies based on hematopoietic stem cell biology. Its lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing hematopoietic cell transplantation.

Status
Merger completed
IPO date
Nov 21, 2019
IPO size
$100M
IPO exchange
NYSE
Target
Jasper Therapeutics, Inc. (Old Jasper)
Announced
May 6, 2021
Closed
Sep 24, 2021
Combined company
Jasper Therapeutics, Inc. (JSPR)
IPO underwriters
American Express Company, Morgan Stanley, Bone and Collegium Pharmaceuticals
SPAC counsel (IPO)
Ellenoff Grossman & Schole
Underwriters' counsel (IPO)
Mayer Brown

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021